The Novel Immunosuppressive Agent Mycophenolate Mofetil Markedly Potentiates the Antiherpesvirus Activities of Acyclovir, Ganciclovir, and Penciclovir in Vitro and in Vivo

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.42.2.216
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

The Antiherpesvirus Activity of H2G [(R)-9-[4-Hydroxy-2-(Hydroxymethyl)Butyl]Guanine] Is Markedly Enhanced by the Novel Immunosuppressive Agent Mycophenolate Mofetil

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1998English

Acyclovir, Ganciclovir, and Zidovudine Transfer Into Rat Milk

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2002English

In Vitro and in Vivo Activities of Zinc Linolenate, a Selective Antibacterial Agent Against Helicobacter Pylori

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

In Vitro and in Vivo Antifungal Activities of Aminopiperidine Derivatives, Novel Ergosterol Synthesis Inhibitors

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2010English

In Vitro and in Vivo Activities of Novel 6-Methylidene Penems as -Lactamase Inhibitors

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2004English

Donepezil Markedly Potentiates Memantine Neurotoxicity in the Adult Rat Brain

Neurobiology of Aging
AgingGerontologyDevelopmental BiologyGeriatricsNeuroscienceNeurology
2008English

In Vitro and in Vivo Antioxidant Activities of Inulin

PLoS ONE
Multidisciplinary
2018English

Prospects for Using Mycophenolate Mofetil in Diffuse Scleroderma

Modern Rheumatology Journal
2009English

Cyclosporine Withdrawal From a Mycophenolate Mofetil-Containing Immunosuppressive Regimen: Results of a Five-Year, Prospective, Randomized Study

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy